Hepatic Vein Transit Time Study: The Effects of Chemotherapy on Hepatic Perfusion: Pump Priming Research Award Winner 2004

Abstract

Get full access to this article

View all access options for this article.

References

Correas

J-M

, Bridal

, Lesavre

, Mejean

Ultrasound contrast agents: properties, principles of action, tolerance and artefacts.

Eur Radiol 2001; 11: 1316 & 1328.

Blomley

MJK

, Albrect

, Cosgrove

, Jayaram

Stimulated acoustic emission in the liver parenchyma with the ultrasound contrast agent Levovist.

Lancet 1998; 351: 568.

Paley

, Ros

PR.

Hepatic metastases.

Radiol Clin N Am 1998; 36: 349 & 363.

Berland

LL.

Slip-ring and conventional dynamic hepatic CT: contrast material and timing considerations.

Radiology 1995; 195: 1 & 8.

Wegener

OH.

Whole Body Computed Tomography. Cambridge: Blackwell Scientific, 1992.

Mathie

, Wheatley

, Blumgart

LH.

Liver blood flow: physiology, measurement, and clinical relevance, in: Surgery of the Liver and Biliary Tract, 2nd edn. Edinburgh: Churchill Livingstone 1994: 95 & 119.

Blomley

MJK

, Coulden

, Dawson

. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 1995; 19: 424 & 433.

Kan

, Ivancev

, Lunderquist

. In vivo microscopy of hepatic tumours in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology 1993; 187: 621 & 626.

Baker

, Pelley

Hepatic metastases: basic principles and implications for radiologists.

Radiology 1995; 197: 329 & 337.

10.

Bang

, Nielson

MB.

Hepatic vein transit time of an ultrasound contrast agent: Simplified procedure using pulse inversion imaging.

Br J Radiol 2001; 74: 752 & 755.

11.

Roche . Phase III Trial in Metastatic Colorectal Carcinoma (NO 16966). Roche Products (Auckland, New Zealand) Ltd, 2004.

12.

National Cancer Institute. Response Evaluation Criteria in Solid Tumours (RECIST) protocol. Maryland: National Cancer Institute, 2000.